Analysts rate Health Catalyst as 'Buy' with a price target of $8.96

Summary

Based on the FactSet survey, analysts give Health Catalyst an average rating of ‘Outperform’ with a target price of $8.96.Trading View

Impact Analysis

The event is classified at the Company Level as it pertains specifically to Health Catalyst and involves analysts’ ratings and target price adjustments. The ‘Outperform’ rating suggests positive sentiment among analysts about Health Catalyst’s future performance. This indicates potential investor confidence and could influence the stock price positively, given the analyst consensus and target price setting expectations for future valuation.Trading View+ 2 The target price of $8.96 reflects a moderate upside potential compared to the current trading price, which may attract investors looking for growth opportunities in the healthcare technology sector. However, potential risks could include the company’s ability to meet growth expectations and external factors like market competition or regulatory changes that might affect its operations. Investors might consider this an opportunity to evaluate their position in Health Catalyst, especially with recent earnings reports and market reactions to these assessments.Yahoo Finance+ 2